Portage Biotech (PRTG) Competitors $4.57 -0.12 (-2.56%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.62 +0.04 (+0.98%) As of 02/21/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PRTG vs. LPTX, MIRA, OKUR, COCP, NNVC, GLYC, MRKR, ATHA, MEIP, and QNTMShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include Leap Therapeutics (LPTX), MIRA Pharmaceuticals (MIRA), OnKure Therapeutics (OKUR), Cocrystal Pharma (COCP), NanoViricides (NNVC), GlycoMimetics (GLYC), Marker Therapeutics (MRKR), Athira Pharma (ATHA), MEI Pharma (MEIP), and Quantum Biopharma (QNTM). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. Leap Therapeutics MIRA Pharmaceuticals OnKure Therapeutics Cocrystal Pharma NanoViricides GlycoMimetics Marker Therapeutics Athira Pharma MEI Pharma Quantum Biopharma Leap Therapeutics (NASDAQ:LPTX) and Portage Biotech (NASDAQ:PRTG) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, community ranking, dividends, analyst recommendations, profitability, earnings and valuation. Is LPTX or PRTG more profitable? Leap Therapeutics' return on equity of -116.24% beat Portage Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Leap TherapeuticsN/A -116.24% -93.18% Portage Biotech N/A -342.34%-196.47% Do analysts rate LPTX or PRTG? Leap Therapeutics presently has a consensus price target of $4.92, suggesting a potential upside of 923.88%. Given Leap Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Leap Therapeutics is more favorable than Portage Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Leap Therapeutics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Portage Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to LPTX or PRTG? In the previous week, Portage Biotech had 1 more articles in the media than Leap Therapeutics. MarketBeat recorded 1 mentions for Portage Biotech and 0 mentions for Leap Therapeutics. Leap Therapeutics' average media sentiment score of 0.00 equaled Portage Biotech'saverage media sentiment score. Company Overall Sentiment Leap Therapeutics Neutral Portage Biotech Neutral Which has more volatility and risk, LPTX or PRTG? Leap Therapeutics has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Does the MarketBeat Community favor LPTX or PRTG? Leap Therapeutics received 281 more outperform votes than Portage Biotech when rated by MarketBeat users. Likewise, 68.53% of users gave Leap Therapeutics an outperform vote while only 59.09% of users gave Portage Biotech an outperform vote. CompanyUnderperformOutperformLeap TherapeuticsOutperform Votes29468.53% Underperform Votes13531.47% Portage BiotechOutperform Votes1359.09% Underperform Votes940.91% Do institutionals and insiders hold more shares of LPTX or PRTG? 30.5% of Leap Therapeutics shares are held by institutional investors. Comparatively, 13.4% of Portage Biotech shares are held by institutional investors. 5.4% of Leap Therapeutics shares are held by company insiders. Comparatively, 42.1% of Portage Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, LPTX or PRTG? Leap Therapeutics is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeap TherapeuticsN/AN/A-$81.41M-$1.93-0.25Portage BiotechN/AN/A-$75.34M-$41.65-0.11 SummaryLeap Therapeutics beats Portage Biotech on 9 of the 14 factors compared between the two stocks. Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.92M$7.06B$5.84B$9.14BDividend YieldN/A2.75%4.75%3.85%P/E Ratio-0.115.7326.0419.11Price / SalesN/A306.03447.4676.36Price / Cash0.5865.6738.0134.83Price / Book1.226.717.644.62Net Income-$75.34M$138.33M$3.18B$245.85M7 Day Performance-0.87%-2.63%-2.00%-2.61%1 Month Performance11.46%-2.33%-0.44%-2.14%1 Year Performance-57.69%-5.33%16.44%12.98% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech0.0855 of 5 stars$4.57-2.6%N/A-46.0%$4.92MN/A-0.116Upcoming EarningsLPTXLeap Therapeutics1.3631 of 5 stars$0.50-0.8%$4.92+876.1%-84.0%$19.30MN/A-0.2640MIRAMIRA Pharmaceuticals2.1109 of 5 stars$1.16-2.5%$14.00+1,106.9%+1.9%$19.21MN/A-2.072OKUROnKure Therapeutics2.6327 of 5 stars$5.74+2.0%$36.00+527.2%N/A$19.17MN/A-0.47N/ACOCPCocrystal Pharma2.6083 of 5 stars$1.87+0.5%$7.00+274.3%+32.7%$19.02MN/A-1.0110NNVCNanoViricidesN/A$1.35+4.7%N/A+21.0%$18.83MN/A-1.7820Gap UpGLYCGlycoMimetics4.1636 of 5 stars$0.29+2.2%$8.00+2,658.6%-90.1%$18.70M$10,000.000.0050Analyst ForecastNews CoverageGap DownHigh Trading VolumeMRKRMarker Therapeutics4.3474 of 5 stars$1.72+1.2%$19.00+1,004.7%-59.9%$18.42M$3.31M0.0060ATHAAthira Pharma2.9125 of 5 stars$0.47+6.4%$13.83+2,855.8%-88.3%$18.10MN/A-0.1640MEIPMEI Pharma4.1543 of 5 stars$2.69-1.1%$7.00+160.2%-41.1%$17.92M$65.30M-0.38100Analyst ForecastGap DownQNTMQuantum BiopharmaN/A$9.02-15.3%N/AN/A$17.32MN/A-0.59N/A Related Companies and Tools Related Companies Leap Therapeutics Alternatives MIRA Pharmaceuticals Alternatives OnKure Therapeutics Alternatives Cocrystal Pharma Alternatives NanoViricides Alternatives GlycoMimetics Alternatives Marker Therapeutics Alternatives Athira Pharma Alternatives MEI Pharma Alternatives Quantum Biopharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTG) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
